Şebnem Erçelen Ceylan is a faculty member in the Department of Biophysics at the Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Türkiye. She received her B.Sc. in Physics Engineering (1995) and M.Sc. in Physics Engineering (1998) from Istanbul Technical University, and earned her Ph.D. in Biophysics from Istanbul University Faculty of Medicine in 2003. She completed a postdoctoral fellowship at the University of Louis Pasteur (Strassbourg University), Faculty of Pharmacy, France, where she focused on chitosan-based non-viral gene delivery systems. Before joining the University of Health Sciences in 2023, she served as a senior researcher at the TÜBİTAK Marmara Research Center, Genetic Engineering and Biotechnology Institute, for more than 25 years. Dr. Erçelen Ceylan has coordinated several national and international research projects, including NATO SPS, TÜBİTAK bilateral collaborations, and has actively contributed to multiple COST Actions, including MC Membership of ENOVA. She has authored more than 20 peer-reviewed scientific articles, several book chapters, and has received over 550 citations. Her current research focuses on nanobiotechnology, vaccine adjuvants and formulations, drug and gene delivery systems, cancer nanomedicine, topical biomedical products, nanovesicular delivery platforms, and physico-chemical and biophysical characterization of therapeutic biomaterials.
Şebnem Erçelen Ceylan is a faculty member in the Department of Biophysics at the Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Türkiye. She received her B.Sc. in Physics Engineering (1995) and M.Sc. in Physics Engineering (1998) from Istanbul Technical University, and earned her Ph.D. in Biophysics from Istanbul University Faculty of Medicine in 2003. She completed a postdoctoral fellowship at the University of Louis Pasteur (Strassbourg University), Faculty of Pharmacy, France, where she focused on chitosan-based non-viral gene delivery systems. Before joining the University of Health Sciences in 2023, she served as a senior researcher at the TÜBİTAK Marmara Research Center, Genetic Engineering and Biotechnology Institute, for more than 25 years. Dr. Erçelen Ceylan has coordinated several national and international research projects, including NATO SPS, TÜBİTAK bilateral collaborations, and has actively contributed to multiple COST Actions, including MC Membership of ENOVA. She has authored more than 20 peer-reviewed scientific articles, several book chapters, and has received over 550 citations. Her current research focuses on nanobiotechnology, vaccine adjuvants and formulations, drug and gene delivery systems, cancer nanomedicine, topical biomedical products, nanovesicular delivery platforms, and physico-chemical and biophysical characterization of therapeutic biomaterials.